Safety and Efficacy of Galvus as add-on Therapy to Metformin Plus Glimepiride

NCT01233622 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

317

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Vildagliptin
DRUG: Placebo

Sponsor

Novartis